Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.

How to buy BioDelivery Sciences International (BDSI) stocks in Canada

Learn how to easily invest in BioDelivery Sciences International stocks.

BioDelivery Sciences International is a drug manufacturers-specialty & generic business based in the US. BioDelivery Sciences International stocks (BDSI.US) are listed on the NASDAQ and all prices are listed in US Dollars. Its last market close was $3.69 – an increase of 9.8% over the previous week. BioDelivery Sciences International employs 176 staff and has a trailing 12-month revenue of around $165.7 million.

How to buy shares in BioDelivery Sciences International

  1. Compare share trading platforms. Use our comparison table to help you find a platform that fits you.
  2. Open your brokerage account. Complete an application with your details.
  3. Confirm your payment details. Fund your account.
  4. Research the stock. Find the stock by name or ticker symbol – BDSI – and research it before deciding if it's a good investment for you.
  5. Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
  6. Check in on your investment. Optimize your portfolio by tracking your stock.

BioDelivery Sciences International stock price (NASDAQ:BDSI)

Use our graph to track the performance of BDSI stocks over time.

BioDelivery Sciences International shares at a glance

Information last updated 2022-01-17.
Latest market close$3.36
52-week range$2.50 - $4.68
50-day moving average $3.01
200-day moving average $3.53
Wall St. target price$6.86
PE ratio 10.5517
Dividend yield N/A (0%)
Earnings per share (TTM) $0.29

Compare online stock trading platforms

Note: The dollar amounts in the table below are in Canadian dollars.

Name Product Finder Rating Stock Trading Fee Account Fee Available Asset Types Offer
FREE TRADES
Wealthsimple Trade
Finder Rating:
★★★★★
3.9 / 5
$0
$0
Stocks, ETFs
Get 2 free stocks when you deposit and trade $150.
Scotia iTRADE
Finder Rating:
★★★★★
3.8 / 5
$4.99 - $9.99
$0
Bonds, Options, Mutual Funds, ETFs, GICs, International Equities
Interactive Brokers
Finder Rating:
★★★★★
4.1 / 5
Min. $1.00, Max. 0.5%
$0
Stocks, Bonds, Options, ETFs, Currencies, Futures
OFFER
CIBC Investor's Edge
Finder Rating:
★★★★★
4 / 5
$4.95 - $6.95
$0 if conditions met, otherwise $100/year
Stocks, Bonds, Options, Mutual Funds, ETFs
Get up to $2,000 cash back. Conditions apply. Offer ends March 1, 2022.
Questrade
Finder Rating:
★★★★★
4.2 / 5
$4.95 - $9.95
$0
Stocks, Bonds, Options, Mutual Funds, ETFs, GICs, International Equities, Precious Metals
Get $50 in free trades when you fund your account with a minimum of $1,000.
Qtrade Direct Investing
Finder Rating:
★★★★★
4.1 / 5
$6.95 - $8.75
$0 if conditions met, otherwise $25/quarter
Stocks, Bonds, Options, Mutual Funds, ETFs, GICs
Get a $50 bonus when you open a new RRSP, TFSA or RESP and start pre-authorized contributions of $200+/month. Valid until March 1, 2022.
loading

Compare up to 4 providers

Online stock trading

Is it a good time to buy BioDelivery Sciences International stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

BioDelivery Sciences International price performance over time

Historical closes compared with the close of $3.36 from 2022-01-21

1 week (2022-01-13) 10.16%
1 month (2021-12-22) 4.02%
3 months (2021-10-18) -17.65%
6 months (2021-07-22) -8.94%
1 year (2021-01-22) -18.84%
2 years (2020-01-22) -41.36%
3 years (2019-01-22) 4.1
5 years (2017-01-20) 76.84%

Is BioDelivery Sciences International under- or over-valued?

Valuing BioDelivery Sciences International stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of BioDelivery Sciences International's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.

BioDelivery Sciences International's P/E ratio

BioDelivery Sciences International's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 11x. In other words, BioDelivery Sciences International shares trade at around 11x recent earnings.

That's relatively low compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The low P/E ratio could mean that investors are pessimistic about the outlook for the shares or simply that they're under-valued.

BioDelivery Sciences International's PEG ratio

BioDelivery Sciences International's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 0.95. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.

The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into BioDelivery Sciences International's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.

BioDelivery Sciences International's EBITDA

BioDelivery Sciences International's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $47.2 million.

The EBITDA is a measure of a BioDelivery Sciences International's overall financial performance and is widely used to measure a its profitability.

BioDelivery Sciences International financials

Revenue TTM $165.7 million
Operating margin TTM 24.32%
Gross profit TTM $131.8 million
Return on assets TTM 10.41%
Return on equity TTM 28.51%
Profit margin 18.81%
Book value $1.24
Market capitalisation $302.3 million

TTM: trailing 12 months

BioDelivery Sciences International share dividends

We're not expecting BioDelivery Sciences International to pay a dividend over the next 12 months.

BioDelivery Sciences International share price volatility

Over the last 12 months, BioDelivery Sciences International's shares have ranged in value from as little as $2.5 up to $4.68. A popular way to gauge a stock's volatility is its "beta".

BDSI.US volatility(beta: 0.86)Avg. volatility(beta: 1.00)LowHigh

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while BioDelivery Sciences International's is 0.8576. This would suggest that BioDelivery Sciences International's shares are less volatile than average (for this exchange).

BioDelivery Sciences International overview

BioDelivery Sciences International, Inc. , a specialty pharmaceutical company, engages in the development and commercialization of pharmaceutical products for chronic conditions in the United States and internationally. The company provides its products based on its patented BioErodible MucoAdhesive drug-delivery technology, a small erodible polymer film for application to the buccal mucosa, as well as other drug-delivery technologies. It offers BELBUCA, a buprenorphine buccal film for the treatment of chronic pain; BUNAVAIL, a buprenorphine and naloxone buccal film to treat opioid dependence; and ONSOLIS, a fentanyl buccal soluble film for the management of breakthrough pain in cancer patients. The company also offers Symproic, a peripherally acting mu-opioid receptor antagonist for the treatment of opioid-induced constipation in adult patients with chronic non-cancer pain, including patients with chronic pain related to prior cancer or its treatment who do not require frequent opioid dosage escalation. BioDelivery Sciences International, Inc. was incorporated in 1997 and is headquartered in Raleigh, North Carolina.

Frequently asked questions

Disclaimer: This information should not be interpreted as an endorsement of futures, stocks, ETFs, CFDs, options or any specific provider, service or offering. It should not be relied upon as investment advice or construed as providing recommendations of any kind. Futures, stocks, ETFs and options trading involves substantial risk of loss and therefore are not appropriate for all investors. Trading CFDs and forex on leverage comes with a higher risk of losing money rapidly. Past performance is not an indication of future results. Consider your own circumstances, and obtain your own advice, before making any trades.

More on investing

More guides on Finder

Go to site